Association between Serum Gamma-glutamyl transferase and Intracranial Arterial Calcification in Acute Ischemic Stroke Subjects

Tao Yao, Jing Li, Qi Long, Gang Li, Yanbin Ding, Qin Cui, Zhichao LiuScientific 2019 · DOI

Introduction

Intracranial arterial calcification (IAC) is a significant risk factor for cerebral infarction and serves as a critical biomarker for intracranial artery stenosis, particularly within Asian populations. While IAC can be visualized through brain computed tomography angiography (CTA), there is a clinical need for accessible blood-based biomarkers to predict its severity and patient prognosis.

Gamma-glutamyl transferase (GGT), an enzyme traditionally associated with liver function and alcohol consumption, has recently emerged as a potential mediator of cardiovascular disease. GGT facilitates the breakdown of extracellular glutathione, a process that can generate reactive oxygen species (ROS). These pro-oxidants contribute to oxidative stress, promoting the oxidation of low-density lipoproteins (LDL) and accelerating atherosclerotic plaque formation and arterial hardening. This study investigates the relationship between serum GGT levels, IAC severity, and clinical outcomes in patients with acute ischemic stroke (AIS).

Methods

This cross-sectional study analyzed 754 patients (mean age: 65 ± 13.2 years) admitted with AIS to the Renmin Hospital of Wuhan University between 2017 and 2018.

The evaluation protocol included:

  • Imaging: Brain CTA was performed on all patients. IAC severity was graded using a 5-point semi-quantitative scoring system across multiple cerebral arteries by two independent neurologists.
  • Biochemical Assessment: Serum GGT levels and other metabolic markers (lipid profiles, homocysteine, blood glucose) were measured upon admission.
  • Statistical Analysis: Logistic regression models were employed to identify independent predictors of mortality, stroke severity (NIHSS scores), and IAC scores, adjusting for potential confounders such as age, gender, smoking status, diabetes, and hypertension.

Results

The study revealed significant associations between elevated GGT levels and adverse outcomes, particularly in male patients.

Mortality and Stroke Severity

Serum GGT levels were significantly higher in patients who died compared to survivors (37.0 ± 26.8 vs 29.0 ± 21.5 U/L, p = 0.012). Logistic regression indicated that GGT independently predicted all-cause mortality in males (OR = 1.036, 95% CI: 1.014-1.060, p = 0.002). Furthermore, each standard deviation increase in serum GGT was associated with a more than twofold increase in mortality risk (OR = 2.272, 95% CI: 1.364-3.787, p = 0.002).

Comparison of serum GGT levels between survivors and deceased patients.

Partial correlation analysis, adjusting for age and gender, demonstrated a positive correlation between serum GGT and NIHSS scores at admission (r = 0.150, p = 0.001), indicating that higher GGT levels are associated with greater neurological impairment.

Correlation between serum GGT levels and NIHSS scores at admission.

Intracranial Arterial Calcification

GGT levels were significantly elevated in patients with severe IAC compared to those with mild or no calcification (37.6 ± 33.6 vs 28.6 ± 19.2, p < 0.001). In male patients, GGT was an independent predictor of IAC scores (β = 0.006, 95% CI: 0.003-0.014, p = 0.005). Interestingly, these associations were not statistically significant in the female subgroup, suggesting potential gender-based differences in vascular pathology or GGT's biological role.

Discussion and Limitations

The findings suggest that GGT serves as more than a liver marker; it likely reflects systemic oxidative stress contributing to arterial "rusting" and calcification. However, several limitations must be considered:

  • Study Design: The retrospective, cross-sectional nature of the study precludes establishing a causal relationship between GGT and IAC or mortality.
  • Gender Disparity: The lack of significant findings in women may be due to the smaller female sample size (n=239) compared to males (n=515).
  • Follow-up Period: The 60-day follow-up captures acute mortality but does not address long-term recurrence or chronic vascular decline.
  • Standardization: The absence of a universal "gold standard" for IAC quantification complicates cross-study comparisons.

In conclusion, serum GGT levels are significantly associated with the risk of death and IAC severity in male AIS patients, highlighting its potential utility as a prognostic biomarker in clinical practice.

Summary updated

Abstract

Intracranial artery calcification (IAC) is an important risk factor for cerebral infarction and a key biomarker for intracranial artery stenosis. Gamma-glutamyl transferase (GGT) has been independently associated with increased cardiovascular events and coronary calcification. Our study assessed whether GGT is an independent factor for IAC in acute ischemic stroke (AIS) patients. This cross-sectional study involved a total of 754 patients with AIS (mean age: 65 ± 13.2 years). All the patients had received brain computed tomography angiography (CTA) examination to evaluate IAC. Further, serum GGT levels and other biochemical parameters were analyzed. The average GGT level in patients who died was also significantly increased (37.0 ± 26.8 vs 29.0 ± 21.5 U/L, p = 0.012). Partial correlation analysis showed that serum GGT levels were associated with NIHSS score at admission after adjustment for age and gender was considered (r = 0.150, p = 0.001). Logistic regression analysis showed that serum GGT levels independently predicted all-cause mortality (OR = 1.036, 95% CI: 1.014-1.060, p = 0.002), NIHSS scores (β = 0.051, 95% CI: 0.020-0.082, p = 0.001) and IAC scores (β = 0.006, 95% CI: 0.003-0.014, p = 0.005) in male patients. Each SD (standard deviation) increase of serum GGT levels was also associated with risk of all-cause mortality (OR = 2.272, 95% CI: 1.364-3.787, P = 0.002). GGT levels in patients with severe IAC were significantly elevated (37.6 ± 33.6 vs 28.6 ± 19.2, p < 0.001). However, serum GGT levels could not independently predict the severity of IAC in AIS patients. Our study identified that serum GGT levels were significantly elevated in patients who died, and the GGT levels had a certain association with the risk of death and IAC in male patients.
BibTeX
@inproceedings{yao2019association,
  author = {Tao Yao and Jing Li and Qi Long and Gang Li and Yanbin Ding and Qin Cui and Zhichao Liu},
  title = {{Association between Serum Gamma-glutamyl transferase and Intracranial Arterial Calcification in Acute Ischemic Stroke Subjects}},
  booktitle = {Scientific},
  year = {2019},
  doi = {10.1038/s41598-019-56569-7},
}
Figure